Single–dose methylphenidate induces shift in functional connectivity associated with positive longer term clinical response in adult attention–deficit/hyperactivity disorder
Scientific Reports,
Journal Year:
2025,
Volume and Issue:
15(1)
Published: Feb. 17, 2025
Language: Английский
Neural basis for individual differences in the attention-enhancing effects of methylphenidate
Proceedings of the National Academy of Sciences,
Journal Year:
2025,
Volume and Issue:
122(13)
Published: March 24, 2025
Stimulant
drugs
that
boost
dopamine,
like
methylphenidate
(MP),
enhance
attention
and
are
effective
treatments
for
attention-deficit
hyperactivity
disorder
(ADHD).
Yet
there
is
large
individual
variation
in
attentional
capacity
response
to
MP.
It
unclear
whether
this
driven
by
differences
relative
density
of
dopamine
receptor
subtypes,
magnitude
increases
induced
MP,
or
both.
Here,
we
extensively
characterized
the
brain
system
with
positron
emission
tomography
(PET)
imaging
(including
striatal
D1
D2/3
availability
MP-induced
increases)
measured
task-evoked
fMRI
activity
two
separate
sessions
(placebo
60
mg
oral
MP;
single-blind,
counterbalanced)
37
healthy
adults.
A
network
lateral
frontoparietal
visual
cortices
was
sensitive
increasing
(and
working
memory)
load,
whose
positively
correlated
performance
across
individuals
(partial
r
=
0.474,
P
0.008;
controlling
age).
change
within
0.686,
<
0.001).
The
ratio
D1-to-D2/3
receptors
dorsomedial
caudate
baseline
negatively
changes
(all
pFWE
0.02).
load
mediated
association
between
improvements
(mediation
estimate
23.20
[95%CI:
-153.67
-81.79],
0.004).
MP
attention-boosting
effects
were
not
linked
increases,
but
rather
showed
dependence
on
an
individual's
density.
Individuals
lower
ratios
tended
have
during
sustained
experienced
greater
improvement
function
task
Language: Английский
Evaluating predictive artificial intelligence approaches used in mobile health platforms to forecast mental health symptoms among youth: a systematic review
Psychiatry Research,
Journal Year:
2024,
Volume and Issue:
343, P. 116277 - 116277
Published: Nov. 19, 2024
The
youth
mental
health
crisis
is
exacerbated
by
limited
access
to
care
and
resources.
Mobile
(mHealth)
platforms
using
predictive
artificial
intelligence
(AI)
can
improve
reduce
barriers,
enabling
real-time
responses
precision
prevention.
This
systematic
review
evaluates
AI
approaches
in
mHealth
for
forecasting
symptoms
among
(13-25
years).
We
searched
studies
from
Embase,
PubMed,
Web
of
Science,
PsycInfo,
CENTRAL,
identify
relevant
studies.
From
11
identified,
three
predicted
multiple
symptoms,
with
depression
being
the
most
common
(63%).
Most
used
smartphones
25%
integrated
wearables.
Key
predictors
included
smartphone
usage
(N=5),
sleep
metrics
(N=6),
physical
activity
(N=5).
Nuanced
like
locations
stages
improved
prediction.
Logistic
regression
was
followed
Support
Vector
Machines
(N=3)
ensemble
methods
(N=4).
F-scores
anxiety
ranged
0.73
0.84,
AUCs
0.50
0.74.
Stress
models
had
0.68
0.83.
Bayesian
model
selection
Shapley
values
enhanced
robustness
interpretability.
Barriers
small
sample
sizes,
privacy
concerns,
missing
data,
underrepresentation
bias.
Rigorous
evaluation
performance,
generalizability,
user
engagement
critical
before
are
into
psychiatric
care.
Language: Английский
Electronic Health Records for Research on Attention-Deficit/Hyperactivity Disorder Pharmacotherapy: A Comprehensive Review
Journal of Child and Adolescent Psychopharmacology,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Sept. 5, 2024
Randomized
controlled
trials
(RCTs)
have
shown
that
attention-deficit/hyperactivity
disorder
(ADHD)
medications
significantly
reduce
symptomatology
at
a
group
level,
but
individual
response
to
ADHD
medication
is
variable.
Thus,
developing
prediction
models
stratify
treatment
according
baseline
clinicodemographic
characteristics
crucial
support
clinical
practice.
A
potential
valuable
source
of
data
develop
accurate
real-world
extracted
from
electronic
healthcare
records
(EHRs).
Yet,
systematic
information
regarding
EHR
on
lacking.
Language: Английский
The long road to precision pediatric sleep medicine
Sleep Medicine Reviews,
Journal Year:
2024,
Volume and Issue:
76, P. 101971 - 101971
Published: June 19, 2024
Language: Английский
Global research progress of electroencephalography applications in attention deficit hyperactivity disorder: Bibliometrics and visualized analysis
Ben Liu,
No information about this author
Xian Liu,
No information about this author
Jie Wei
No information about this author
et al.
Medicine,
Journal Year:
2024,
Volume and Issue:
103(38), P. e39668 - e39668
Published: Sept. 20, 2024
Attention
deficit
hyperactivity
disorder
(ADHD)
is
a
profound
neurodevelopmental
disorder.
Currently,
the
diagnosis
of
ADHD
relies
on
clinical
assessments
and
lacks
objective
testing.
Research
in
electroencephalography
(EEG)
offers
new
hope
for
ADHD,
with
researchers
actively
seeking
EEG
biomarkers.
This
study
conducts
bibliometric
analysis
application
aiming
to
provide
brief
overview
characteristics,
main
research
areas,
development
paths,
trends
this
field.
The
Web
Science
Core
Collection
was
queried
June
10,
2024,
gather
relevant
scholarly
works
from
period
2004
2023.
Analysis
conducted
using
CiteSpace,
VOSviewer,
Microsoft
Excel
2019.
In
past
20
years,
1162
documents
qualified,
swift
rise
annual
publications.
USA,
University
London,
Barry
RJ
led
productivity
impact,
while
Clinical
Neurophysiology
topped
publication
volume
citations.
High-frequency
terms
include
"ADHD,"
"EEG,"
"event-related
potentials
(ERP),"
"children,"
"neurofeedback."
Clustering
key
such
as
"cognitive
control,"
"theta
waves,"
"epilepsy,"
"graph
theory,"
"machine
learning,"
"neurofeedback"
form
cornerstone
current
core
areas.
At
same
time,
series
emerging
frontiers
are
gradually
emerging,
including
"theta/beta
ratio
(TBR),"
"P300
wave,"
"neurofeedback,"
"deep
learning."
Over
2
decades,
has
been
burgeoning,
themes
becoming
increasingly
profound.
These
insights
guidance
trends,
trajectories,
future
challenges
Language: Английский
Commentary: Using QbTest for monitoring pharmacological treatment response in ADHD – are we there yet?
Journal of Child Psychology and Psychiatry,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Nov. 8, 2024
Individuals
with
attention-deficit/hyperactivity
disorder
(ADHD)
exhibit
varied
responses
to
pharmacological
treatments
(e.g.
stimulants
and
non-stimulants).
Accurately
promptly
detecting
treatment-related
improvements,
response
failure,
or
deterioration
poses
significant
challenges,
as
current
monitoring
primarily
relies
on
subjective
ratings.
In
this
commentary,
we
critically
evaluate
the
evidence
supporting
use
of
QbTest
for
objectively
ADHD
treatment
in
clinical
practice.
We
also
offer
recommendations
future
research,
advocating
rigorous
trials
longitudinal
studies
further
explore
potential
utilisation
other
tools
individuals
ADHD.
Language: Английский